J.-P. Persijn

1.0k total citations
35 papers, 865 citations indexed

About

J.-P. Persijn is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, J.-P. Persijn has authored 35 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in J.-P. Persijn's work include Estrogen and related hormone effects (7 papers), Adenosine and Purinergic Signaling (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). J.-P. Persijn is often cited by papers focused on Estrogen and related hormone effects (7 papers), Adenosine and Purinergic Signaling (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). J.-P. Persijn collaborates with scholars based in Netherlands, United States and Sweden. J.-P. Persijn's co-authors include W. van der Slik, A. Riethorst, E Engelsman, F. J. Cleton, L.W. Statius van Eps, A. J. G. Swaak, J. P. A. Baak, Stig Kullander, P Rümke and Lars Göran Friberg and has published in prestigious journals such as The Lancet, Cancer and British Journal of Cancer.

In The Last Decade

J.-P. Persijn

35 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-P. Persijn Netherlands 15 193 184 175 109 80 35 865
Laurens P. White United States 17 193 1.0× 94 0.5× 199 1.1× 117 1.1× 42 0.5× 34 905
Ronald W. Walenga United States 20 501 2.6× 115 0.6× 84 0.5× 89 0.8× 100 1.3× 51 1.5k
G. L. Floersheim Switzerland 19 257 1.3× 85 0.5× 111 0.6× 62 0.6× 156 1.9× 71 1.0k
J. W. Keyser United Kingdom 13 211 1.1× 57 0.3× 99 0.6× 42 0.4× 44 0.6× 46 610
D N Croft United Kingdom 20 129 0.7× 97 0.5× 75 0.4× 96 0.9× 28 0.3× 43 1.0k
Sally M. Fuerstenberg Sweden 8 505 2.6× 71 0.4× 102 0.6× 130 1.2× 49 0.6× 9 1.2k
Frank K. Jugert Germany 18 467 2.4× 172 0.9× 200 1.1× 64 0.6× 36 0.5× 35 1.4k
C. M. Payne United States 14 470 2.4× 89 0.5× 341 1.9× 164 1.5× 26 0.3× 27 1.1k
Lester W. Schwartz United States 15 290 1.5× 111 0.6× 66 0.4× 103 0.9× 47 0.6× 28 966
Ward Jm United States 16 304 1.6× 80 0.4× 262 1.5× 86 0.8× 20 0.3× 34 950

Countries citing papers authored by J.-P. Persijn

Since Specialization
Citations

This map shows the geographic impact of J.-P. Persijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Persijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Persijn more than expected).

Fields of papers citing papers by J.-P. Persijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Persijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Persijn. The network helps show where J.-P. Persijn may publish in the future.

Co-authorship network of co-authors of J.-P. Persijn

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Persijn. A scholar is included among the top collaborators of J.-P. Persijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Persijn. J.-P. Persijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kloosterman, A., et al.. (1984). Comparison of enzyme assay and radioimmunoassay for the measurement of human acid phosphatase in cases of sexual assault. Forensic Science International. 25(1). 45–55. 15 indexed citations
2.
Persijn, J.-P. & A. A. M. Hart. (1981). Prognostic Significance of CEA in Colorectal Cancer: A Statistical Study. Clinical evaluation of carcino-embryonic antigen, V. Clinical Chemistry and Laboratory Medicine (CCLM). 19(11). 1117–1124. 9 indexed citations
3.
Jong‐Bakker, M. De, Augustinus A. M. Hart, J.-P. Persijn, & F. J. Cleton. (1981). Prognostic significance of CEA in breast cancer: a statistical study. European Journal of Cancer and Clinical Oncology. 17(12). 1307–1313. 25 indexed citations
4.
Slik, W. van der, et al.. (1980). Automated Method for the Determination of 5′-Nucleotidase in Serum by Continuous Flow Analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 18(6). 333–338. 2 indexed citations
5.
Eps, L.W. Statius van, et al.. (1980). Urinaryβ2-Microglobulin Excretion in Urinary Tract Infections. Acta Clinica Belgica. 35(sup10). 21–29. 6 indexed citations
6.
Friberg, Lars Göran, et al.. (1978). On receptors for estrogens (e2) and androgens (dht) in human endometrial carcinoma and ovarian tumours. Acta Obstetricia Et Gynecologica Scandinavica. 57(3). 261–264. 37 indexed citations
7.
Persijn, J.-P., et al.. (1977). Evaluation of and Additional Data on an Improved Simple Charcoal Method to Determine Oestrogen Receptors. Clinical Chemistry and Laboratory Medicine (CCLM). 15(1-12). 297–301. 8 indexed citations
9.
Persijn, J.-P., et al.. (1976). Carcino-Embryonic Antigen Activity in Urine of Patients with Bladder Carcinoma.Clinical Evaluation of Carcino-Embryonic Antigen, II.. Clinical Chemistry and Laboratory Medicine (CCLM). 14(1-12). 389–394. 5 indexed citations
10.
Persijn, J.-P., et al.. (1976). The Development of a Radioimmuno-Assay for Carcino-Embryonic Antigen with some Applications. Clinical Evaluation of Cercino-Ernbryonic Antigen, I. Clinical Chemistry and Laboratory Medicine (CCLM). 14(1-12). 377–87. 5 indexed citations
11.
Persijn, J.-P., et al.. (1975). Oestrogen and androgen receptors in breast cancer and response to endocrine therapy.. BMJ. 4(5995). 503–503. 43 indexed citations
12.
Engelsman, E, et al.. (1974). ANTI-ŒSTROGENS AND BREAST CANCER. The Lancet. 304(7873). 171–172. 1 indexed citations
13.
Engelsman, E, et al.. (1974). Proceedings: Oestrogen and androgen receptors in human breast cancer. British Journal of Cancer. 30(2). 177–177. 16 indexed citations
14.
Persijn, J.-P., et al.. (1974). The Application of the Serum γ-Glutamyl Transpeptidase and the 5’-Nucleotidase Assay in Cancer Patients: A Comparative Study. Clinical Chemistry and Laboratory Medicine (CCLM). 12(3). 116–120. 6 indexed citations
15.
Engelsman, E, et al.. (1973). Oestrogen Receptor in Human Breast Cancer Tissue and Response to Endocrine Therapy. BMJ. 2(5869). 750–752. 62 indexed citations
16.
Persijn, J.-P., et al.. (1972). A Simple Assay for Specific Estrogen Binding Capacity in Human Mammary Tumours. Clinical Chemistry and Laboratory Medicine (CCLM). 10(11). 5 indexed citations
17.
Persijn, J.-P., et al.. (1971). Colorimetric assay for γ-glutamyl transpeptidase. Clinica Chimica Acta. 35(1). 239–240. 20 indexed citations
18.
Slik, W. van der, J.-P. Persijn, E Engelsman, & A. Riethorst. (1970). Serum 5′-Nucleotidase. Clinical Biochemistry. 3(1). 59–80. 13 indexed citations
19.
Slik, W. van der, et al.. (1970). Serum 5′-nucleotidase. Clinical Biochemistry. 3(1). 59–80. 3 indexed citations
20.
Persijn, J.-P., et al.. (1969). A New Method for the Determination of Serum Nucleotidase. III Inhibition of alkaline phosphatase. Clinical Chemistry and Laboratory Medicine (CCLM). 7(5). 493–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026